- Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Flinn, I.W., Spigel, D.R., Clark, B.L., Griner, P.L., Vazquez, E.R., Doss, H.H., Shipley, D., Franco, L.A., Burris, H.A., Greco, F.A. Clin. Lymphoma. Myeloma. Leuk (2010)